Mycobacterium Citations List: September 2024

Literature Citations

1. Design, Synthesis, In Vitro and In Silico Studies of Novel Piperidine Derived Thiosemicarbazones as Inhibitors of Dihydrofolate Reductase. Aftab, H., S. Ullah, A. Khan, M. Al-Rashida, T. Islam, K.A. Dahlous, S. Mohammad, H. Kashtoh, A. Al-Harrasi, and Z. Shafiq. Scientific Reports, 2024. 14(1): 22645. PMID[39349528].
[PubMed]. TB_09_2024.

2. The Use of Dual Β-Lactams to Restore Susceptibility of Mycobacterium avium Complex. Al-Jabri, M.Y., K.M. Dousa, B.M. Wilson, and R.A. Bonomo. Antimicrobial Resistance, 2024. 6(5): dlae142. PMID[39281290]. PMCID[PMC11398912].
[PubMed]. TB_09_2024.

3. Benzenesulfonohydrazide-tethered Non-fused and Fused Heterocycles as Potential Anti-mycobacterial Agents Targeting Enoyl Acyl Carrier Protein Reductase (InhA) with Antibiofilm Activity. Al-Warhi, T., A. Sabt, M. Korycka-Machala, A.F. Kassem, M.A. Shaldam, H.A.A. Ibrahim, M. Kawka, B. Dziadek, M. Kuzioła, W.M. Eldehna, and J. Dziadek. RSC Advances, 2024. 14(41): p. 30165-30179. PMID[39315015]. PMCID[PMC11418391].
[PubMed]. TB_09_2024.

4. Design, Synthesis, Anti-tubercular Activity, and Computational Studies of Novel 3-(quinolin-3-yl)-1-phenylprop-2-en-1-one Derivatives. Bhanwala, N., N.S. Sundaramoorthy, S. Gollapudi, A. Sharma, R. Singh, and G.L. Khatik. Medicinal Chemistry Research, 2024. ISI[001309896000001].
[WOS]. TB_09_2024.

5. Substituent-oriented Synthesis of Substituted Pyridines/Pyrido[3,2-C]coumarins Via Sequential Reactions of α-H and Me/Aryl Substituted Oxime Acetates and 3-formylchromones. Bodala, V., R.L. Podugu, K. Yettula, S.K. Kadiri, and S. Vidavalur. The Journal of Organic Chemistry, 2024. 89(18): p. 12957-12966. PMID[39196990].
[PubMed]. TB_09_2024.

6. Target-directed Dynamic Combinatorial Chemistry Affords Binders of Mycobacterium tuberculosis IspE. Braun-Cornejo, M., C. Ornago, V. Sonawane, J. Haupenthal, A.M. Kany, E. Diamanti, G. Jézéquel, N. Reiling, W. Blankenfeldt, P. Maas, and A.K.H. Hirsch. ACS Omega, 2024. 9(36): p. 38160-38168. PMID[39281890]. PMCID[PMC11391541].
[PubMed]. TB_09_2024.

7. Metal Complexes of Curcumin: A Comprehensive Approach to Design, Synthesis, Characterization and Assessment of Anti-tubercular Activity. Das, P., H.M. Yamuna, M. Harshashree, and R. Dang. Indian Journal of Pharmaceutical Education and Research, 2024. 58(3): p. s963-s972. ISI[001292656700024].
[WOS]. TB_09_2024.

8. Discovery and Biosynthesis of Persiathiacins: Unusual Polyglycosylated Thiopeptides Active against Multidrug Resistant Tuberculosis. Dashti, Y., F. Mohammadipanah, Y. Zhang, P.M. Cerqueira Diaz, A. Vocat, D. Zabala, C.D. Fage, I. Romero-Canelon, B. Bunk, C. Spröer, L.M. Alkhalaf, J. Overmann, S.T. Cole, and G.L. Challis. ACS Infectious Diseases, 2024. 10(9): p. 3378-3391. PMID[39189814]. PMCID[PMC11406533].
[PubMed]. TB_09_2024.

9. Challenging the Biginelli Scaffold to Surpass the First Line Antitubercular Drugs: Mycobacterium tuberculosis Thymidine Monophosphate Kinase (TMPK mt) Inhibition Activity and Molecular Modelling Studies. El-Shoukrofy, M.S., A. Atta, S. Fahmy, D. Sriram, M.G. Shehat, I.M. Labouta, and M.A. Mahran. Journal of Enzyme Inhibition and Medicinal Chemistry, 2024. 39(1): 2386668. PMID[39258667]. PMCID[PMC11391879].
[PubMed]. TB_09_2024.

10. Design, Synthesis, Evaluation, and Molecular Docking Study of Novel Quinoline Hydrazone Analogues as Anti-tubercular Agents. Gupta, V., N.S. Sundaramoorthy, N. Bhanwala, R. Ambatwar, S. Kumar, R. Singh, and G.L. Khatik. Journal of Computational Biophysics and Chemistry, 2024. ISI[001306329700001].
[WOS]. TB_09_2024.

11. Preclinical Tests for Salicylhydrazones Derivatives to Explore Their Potential for New Antituberculosis Agents. Ieque, A.L., C.T. Palomo, V. Gabriela de Freitas Spanhol, M.L. Fróes da Motta Dacome, J. Júnior do Carmo Pereira, F.C. Candido, K.R. Caleffi-Ferracioli, V.L. Dias Siqueira, R.F. Cardoso, F. Vandresen, V.G. Alves-Olher, and R.B. de Lima Scodro. Tuberculosis, 2024. 148: 102545. PMID[39079220].
[PubMed]. TB_09_2024.

12. Design and Synthesis of Non-hydroxamate Lipophilic Inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): In Silico, In Vitro and Antibacterial Studies. Kesharwani, S., Eeba, M. Tandi, N. Agarwal, and S. Sundriyal. RSC Advances, 2024. 14(38): p. 27530-27554. PMID[39221132]. PMCID[PMC11362829].
[PubMed]. TB_09_2024.

13. Investigation of Novel 2-(chloromethyl)-5-(3, 5-disubstituted-1h-indol-2-yl)-1,3,4-oxadiazole Derivatives as In Vitro, and In Silico Bioactivity Potential: Anti-inflammatory, Anti-Tb and Antioxidant Activities Study. Kumar, K.H., B.T. Sridhar, P. Karunakar, G.Y. Nagesh, N. Gupta, S.P. Jisha, and S.M. Basavarajaiah. Chemistryselect, 2024. 9(33): e202401756. ISI[001303864300001].
[WOS]. TB_09_2024.

14. Investigation of Biological Activity of Oxindole Semicarbazones Based Copper (II) Complexes: Synthesis, Antimicrobial Activities and Molecular Modelling. Mir, I.A., Q. Ul Ain, I. Singh, R. Carmieli, and R. Sharma. Polyhedron, 2024. 263: 117208. ISI[001309038700001].
[WOS]. TB_09_2024.

15. Development and Evaluation of Bis-benzothiazoles as a New Class of Benzothiazoles Targeting DprE1 as Antitubercular Agents. Samoon, R., S. Sau, A. Roy, K.K. Parida, K. Sharma, P.A. Yakkala, R.P. Dewangan, M.Z. Abdin, N.P. Kalia, and S. Shafi. ACS Infectious Diseases, 2024. 10(9): p. 3320-3331. PMID[39150887].
[PubMed]. TB_09_2024.

16. A Quest for Novel Antimicrobial Targets: Inhibition of Asp-tRNA(Asn)/Glu-tRNA(Gln) Amidotransferase (GatCAB) by Synthetic Analogs of Aminoacyl-adenosine In Vitro and Live Bacteria. Sangsuwan, W., A. Taweesablamlert, A. Boonkerd, C. Isarangkool Na Ayutthaya, S. Yoo, B. Javid, K. Faikhruea, T. Vilaivan, C. Aonbangkhen, and P. Chuawong. Bioorg Chem, 2024. 150: 107530. PMID[38852310].
[PubMed]. TB_09_2024.

17. Targeted Hybridization: Pyrazine-2-carbohydrazide Derivatives as Promising Antitubercular and Antimicrobial Leads. Siddiki, A.A., S. Parmar, H.K. Chaudhari, S.S.P. Yadav, and R.S. Chauhan. Chemistryselect, 2024. 9(36): e202402487. ISI[001315291200001].
[WOS]. TB_09_2024.

18. Novel Hybrids of 1,2,3-triazole-benzoxazole: Design, Synthesis, and Assessment of DprE1 Enzyme Inhibitors Using Fluorometric Assay and Computational Analysis. Singh, M., S.M. Batt, C.S.C. Canales, F.R. Pavan, S.A. Kumar, H.S. Akshatha, M. Bhagyalalitha, K.G. Pujar, D. Bidye, G.V. Pujar, and G.S. Besra. Journal of Enzyme Inhibition and Medicinal Chemistry, 2024. 39(1): 2403744. PMID[39329328]. PMCID[PMC11441021]
[PubMed]. TB_09_2024.

19. Design, Synthesis, and Evaluation of the Antitubercular Activity of 5-phenyl substituted-5, 6-dihydropyrido[2, 3-D]pyrimidine-4, 7(3h, 8h)-dione Compounds. Sun, L., S. Kou, B. Wang, Y. Wang, J. Meng, T. Liu, Y. Ma, J. Zhao, H. Yi, S. Cen, Y. Lu, and Z. Li. Journal of Medicinal Chemistry, 2024. 67(17): p. 14927-14945. PMID[39166949].
[PubMed]. TB_09_2024.

20. The Repurposing of FDA-approved Drugs as FtsZ Inhibitors against Mycobacterium tuberculosis: An In Silico and In Vitro Study. Tovar-Nieto, A.M., L.E. Flores-Padilla, B. Rivas-Santiago, J.V. Trujillo-Paez, E.E. Lara-Ramirez, Y.M. Jacobo-Delgado, J.E. López-Ramos, and A. Rodríguez-Carlos. Microorganisms, 2024. 12(8): 1505. PMID[39203348]. PMCID[PMC11356655].
[PubMed]. TB_09_2024.

Patent Citations

This month, no relevant Mycobacterium patents were identified.